Fig. 1From: Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrenceHCV viral load is reduced significantly in liver transplant patients treated with iv-SIL (20Â mg/kg/day) for 14 consecutive days. The box and whisker plots show mean and min to max values before (pre) and after treatment (post)Back to article page